OUP Management

Latest statistics and disclosures from OUP Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are CNTA, AVTE, Cyteir Therapeutics, PMVP, Graphite Bio, and represent 92.80% of OUP Management's stock portfolio.
  • Added to shares of these 1 stock: IKNA.
  • Started 1 new stock position in IKNA.
  • Reduced shares in these 1 stock: Dice Therapeutics (-$13M).
  • Sold out of its position in Dice Therapeutics.
  • OUP Management was a net seller of stock by $-12M.
  • OUP Management has $45M in assets under management (AUM), dropping by -24.16%.
  • Central Index Key (CIK): 0001880124

Tip: Access up to 7 years of quarterly data

Positions held by OUP Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for OUP Management

OUP Management holds 12 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Centessa Pharmaceuticals Sponsored ADS (CNTA) 42.7 $19M 2.9M 6.47
 View chart
Aerovate Therapeutics Common Stock (AVTE) 18.4 $8.2M 604k 13.57
 View chart
Cyteir Therapeutics Common Stock 15.7 $7.0M 2.5M 2.84
 View chart
PMV Pharmaceuticals Common Stock (PMVP) 13.7 $6.1M 989k 6.14
 View chart
Graphite Bio Common Stock 2.3 $1.0M 406k 2.48
 View chart
Selecta Biosciences Common Stock (RNAC) 2.1 $914k 863k 1.06
 View chart
Vor Biopharma Common Stock (VOR) 1.8 $794k 375k 2.12
 View chart
eFFECTOR Therapeutics Common Stock 1.4 $615k 1.0M 0.60
 View chart
Precision BioSciences Common Stock 0.9 $384k 1.1M 0.34
 View chart
Spero Therapeutics Common Stock (SPRO) 0.7 $301k 249k 1.21
 View chart
Ikena Oncology Common Stock (IKNA) 0.3 $116k NEW 27k 4.33
 View chart
Homology Medicines Common Stock 0.2 $75k 64k 1.17
 View chart

Past Filings by OUP Management

SEC 13F filings are viewable for OUP Management going back to 2021